位置:首页 > 蛋白库 > GRDN_MOUSE
GRDN_MOUSE
ID   GRDN_MOUSE              Reviewed;        1873 AA.
AC   Q5SNZ0; Q5M6X2; Q5M6X4; Q5M6X5; Q5SNZ1; Q8C486; Q8CFU7;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   15-MAY-2007, sequence version 2.
DT   03-AUG-2022, entry version 140.
DE   RecName: Full=Girdin;
DE   AltName: Full=Akt phosphorylation enhancer;
DE            Short=APE;
DE   AltName: Full=Coiled-coil domain-containing protein 88A;
DE   AltName: Full=G alpha-interacting vesicle-associated protein;
DE            Short=GIV;
DE   AltName: Full=Girders of actin filament;
DE   AltName: Full=Hook-related protein 1;
DE            Short=HkRP1;
GN   Name=Ccdc88a; Synonyms=Grdn, Kiaa1212;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:BAD98263.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, INTERACTION WITH AKT1,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Embryo {ECO:0000269|PubMed:15753085};
RX   PubMed=15753085; DOI=10.1074/jbc.m500586200;
RA   Anai M., Shojima N., Katagiri H., Ogihara T., Sakoda H., Onishi Y., Ono H.,
RA   Fujishiro M., Fukushima Y., Horike N., Viana A., Kikuchi M., Noguchi N.,
RA   Takahashi S., Takata K., Oka Y., Uchijima Y., Kurihara H., Asano T.;
RT   "A novel protein kinase B (PKB)/AKT-binding protein enhances PKB kinase
RT   activity and regulates DNA synthesis.";
RL   J. Biol. Chem. 280:18525-18535(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAH37020.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1086-1873 (ISOFORMS 2/3).
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:AAH37020.1};
RC   TISSUE=Retina {ECO:0000312|EMBL:AAH37020.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:BAC38612.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1623-1873.
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:BAC38612.1};
RC   TISSUE=Embryonic stem cell {ECO:0000312|EMBL:BAC38612.1};
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1677, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic brain;
RX   PubMed=15345747; DOI=10.1074/mcp.m400085-mcp200;
RA   Ballif B.A., Villen J., Beausoleil S.A., Schwartz D., Gygi S.P.;
RT   "Phosphoproteomic analysis of the developing mouse brain.";
RL   Mol. Cell. Proteomics 3:1093-1101(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [7] {ECO:0000305}
RP   SUBUNIT, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=15882442; DOI=10.1111/j.1600-0854.2005.00289.x;
RA   Simpson F., Martin S., Evans T.M., Kerr M., James D.E., Parton R.G.,
RA   Teasdale R.D., Wicking C.;
RT   "A novel hook-related protein family and the characterization of hook-
RT   related protein 1.";
RL   Traffic 6:442-458(2005).
RN   [8] {ECO:0000305}
RP   REVIEW.
RX   PubMed=17185515; DOI=10.1196/annals.1377.016;
RA   Enomoto A., Ping J., Takahashi M.;
RT   "Girdin, a novel actin-binding protein, and its family of proteins possess
RT   versatile functions in the Akt and Wnt signaling pathways.";
RL   Ann. N. Y. Acad. Sci. 1086:169-184(2006).
RN   [9]
RP   FUNCTION, INTERACTION WITH DISC1 AND AKT PROTEINS, AND TISSUE SPECIFICITY.
RX   PubMed=19778506; DOI=10.1016/j.neuron.2009.08.008;
RA   Kim J.Y., Duan X., Liu C.Y., Jang M.H., Guo J.U., Pow-anpongkul N.,
RA   Kang E., Song H., Ming G.L.;
RT   "DISC1 regulates new neuron development in the adult brain via modulation
RT   of AKT-mTOR signaling through KIAA1212.";
RL   Neuron 63:761-773(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-233; SER-237 AND SER-1677,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Lung, Spleen, and
RC   Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [11]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=26917597; DOI=10.1093/brain/aww014;
RA   Nahorski M.S., Asai M., Wakeling E., Parker A., Asai N., Canham N.,
RA   Holder S.E., Chen Y.C., Dyer J., Brady A.F., Takahashi M., Woods C.G.;
RT   "CCDC88A mutations cause PEHO-like syndrome in humans and mouse.";
RL   Brain 139:1036-1044(2016).
CC   -!- FUNCTION: Bifunctional modulator of guanine nucleotide-binding proteins
CC       (G proteins) (By similarity). Acts as a non-receptor guanine nucleotide
CC       exchange factor which binds to and activates guanine nucleotide-binding
CC       protein G(i) alpha subunits (By similarity). Also acts as a guanine
CC       nucleotide dissociation inhibitor for guanine nucleotide-binding
CC       protein G(s) subunit alpha GNAS (By similarity). Essential for cell
CC       migration (By similarity). Interacts in complex with G(i) alpha
CC       subunits with the EGFR receptor, retaining EGFR at the cell membrane
CC       following ligand stimulation and promoting EGFR signaling which
CC       triggers cell migration (By similarity). Binding to Gi-alpha subunits
CC       displaces the beta and gamma subunits from the heterotrimeric G-protein
CC       complex which enhances phosphoinositide 3-kinase (PI3K)-dependent
CC       phosphorylation and kinase activity of AKT1/PKB (By similarity).
CC       Phosphorylation of AKT1/PKB induces the phosphorylation of downstream
CC       effectors GSK3 and FOXO1/FKHR, and regulates DNA replication and cell
CC       proliferation (PubMed:15753085). Binds in its tyrosine-phosphorylated
CC       form to the phosphatidylinositol 3-kinase (PI3K) regulatory subunit
CC       PIK3R1 which enables recruitment of PIK3R1 to the EGFR receptor,
CC       enhancing PI3K activity and cell migration (By similarity). Plays a
CC       role as a key modulator of the AKT-mTOR signaling pathway, controlling
CC       the tempo of the process of newborn neuron integration during adult
CC       neurogenesis, including correct neuron positioning, dendritic
CC       development and synapse formation (PubMed:19778506). Inhibition of G(s)
CC       subunit alpha GNAS leads to reduced cellular levels of cAMP and
CC       suppression of cell proliferation (By similarity). Essential for the
CC       integrity of the actin cytoskeleton (By similarity). Required for
CC       formation of actin stress fibers and lamellipodia (By similarity). May
CC       be involved in membrane sorting in the early endosome (By similarity).
CC       Plays a role in ciliogenesis and cilium morphology and positioning and
CC       this may partly be through regulation of the localization of
CC       scaffolding protein CROCC/Rootletin (By similarity).
CC       {ECO:0000250|UniProtKB:Q3V6T2, ECO:0000269|PubMed:15753085,
CC       ECO:0000269|PubMed:19778506}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts (via GBA motif) with
CC       guanine nucleotide-binding protein G(i) alpha subunits GNAI1, GNAI2 and
CC       GNAI3 (By similarity). Also interacts (via GNA motif) with guanine
CC       nucleotide-binding protein G(s) alpha subunit GNAS (By similarity).
CC       Interaction with G(i) alpha subunits occurs before interaction with
CC       GNAS and is regulated by phosphorylation; phosphorylation at Ser-1677
CC       enhances binding to G(i) alpha subunits while phosphorylation at Ser-
CC       1692 abolishes G(i) alpha subunit binding, promoting binding to GNAS
CC       (By similarity). Interacts (via C-terminal SH2-like region) with growth
CC       factor receptors EGFR, INSR and KDR/VEGFR2 (via their
CC       autophosphorylated cytoplasmic tails) (By similarity). Forms a complex
CC       with EGFR and GNAI3 which leads to enhanced EGFR signaling and
CC       triggering of cell migration; ligand stimulation is required for
CC       recruitment of GNAI3 to the complex (By similarity). Interacts
CC       (tyrosine-phosphorylated form) with phosphatidylinositol 3-kinase
CC       (PI3K) regulatory subunit PIK3R1/p85a (via SH2 domains); the
CC       interaction enables recruitment of PIK3R1 to the EGFR receptor,
CC       enhancing PI3K activity and cell migration (By similarity). Interacts
CC       with serine/threonine-protein kinase PRKCQ; the interaction leads to
CC       phosphorylation of CCDC88A and inhibition of its guanine nucleotide
CC       exchange factor activity (By similarity). Interacts (via C-terminus)
CC       with DISC1; the interaction is direct (PubMed:19778506). Interacts with
CC       AKT proteins; the interaction is inhibited in the presence of DISC1
CC       (PubMed:19778506). Interacts with AKT1/PKB (via C-terminus)
CC       (PubMed:15753085). The non-phosphorylated form interacts with
CC       phosphatidylinositol 4-phosphate [Pi(4)P] and weakly with
CC       phosphatidylinositol 3-phosphate [Pi(3)P] (By similarity). Interacts
CC       with microtubules (PubMed:15882442). Interacts with actin (By
CC       similarity). {ECO:0000250|UniProtKB:Q3V6T2,
CC       ECO:0000269|PubMed:15753085, ECO:0000269|PubMed:15882442,
CC       ECO:0000269|PubMed:19778506}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q3V6T2};
CC       Peripheral membrane protein {ECO:0000305}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q3V6T2}. Cytoplasmic vesicle
CC       {ECO:0000250|UniProtKB:Q3V6T2}. Cell projection, lamellipodium
CC       {ECO:0000250|UniProtKB:Q3V6T2}. Cytoplasm, cytoskeleton, cilium basal
CC       body {ECO:0000250|UniProtKB:Q3V6T2}. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome, centriole
CC       {ECO:0000250|UniProtKB:Q3V6T2}. Note=Localizes to the cytosol in
CC       unstimulated cells while EGF stimulation promotes membrane localization
CC       and guanine nucleotide exchange factor activity (By similarity).
CC       Localizes to the cell membrane through interaction with
CC       phosphoinositides (By similarity). {ECO:0000250|UniProtKB:Q3V6T2}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q5SNZ0-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:15753085};
CC         IsoId=Q5SNZ0-2; Sequence=VSP_052411;
CC       Name=3;
CC         IsoId=Q5SNZ0-3; Sequence=VSP_052410, VSP_052411;
CC   -!- TISSUE SPECIFICITY: Expressed in the dentate gyrus, pyramidal cell
CC       layer of hippocampal regions CA1 and CA3 at postnatal 15. Expressed
CC       highly in neurons. Weakly in neuron progenitors (at protein level).
CC       Expressed in the dentate granule cell layer of the hippocampus.
CC       Expressed highly in the adult testis, moderately in the brain and at a
CC       low level in the spleen, lungs and fat. {ECO:0000269|PubMed:15753085,
CC       ECO:0000269|PubMed:15882442, ECO:0000269|PubMed:19778506}.
CC   -!- DEVELOPMENTAL STAGE: Temporally and spatially restricted during
CC       embryogenesis. At 10.5 dpc, expressed in the branchial arches, nasal
CC       processes, limbs, somites and dorsal root ganglia. At 11.5 dpc,
CC       expression persists at these sites in addition to the eye and fore-,
CC       mid- and hindbrain. By 12.5 dpc, expressed in the interdigital
CC       mesenchyme of the limbs. At 13.5 dpc, expression in the limbs flanks
CC       the digits and also appears in a subset of tendons in the hind- and
CC       forelimbs. {ECO:0000269|PubMed:15882442}.
CC   -!- DOMAIN: The GBA (G-alpha binding and activating) motif mediates binding
CC       to the alpha subunits of guanine nucleotide-binding proteins (G
CC       proteins). {ECO:0000250|UniProtKB:Q3V6T2}.
CC   -!- DOMAIN: In the presence of tyrosine-autophosphorylated growth factor
CC       receptors, the C-terminus folds into an SH2-like region which promotes
CC       the stable recruitment of CCDC88A to the growth factor receptors. The
CC       SH2-like region is phosphorylated by the growth factor receptors prior
CC       to completion of folding. {ECO:0000250|UniProtKB:Q3V6T2}.
CC   -!- PTM: Phosphorylation is induced by epidermal growth factor (EGF) in a
CC       phosphoinositide 3-kinase (PI3K)-dependent manner (By similarity).
CC       Phosphorylation by AKT1/PKB is necessary for the delocalization from
CC       the cell membrane and for cell migration (By similarity).
CC       Phosphorylated on tyrosine residues which promotes binding to
CC       phosphatidylinositol 3-kinase (PI3K) regulatory subunit PIK3R1/p85a and
CC       enhances PI3K activity (By similarity). Tyrosine-phosphorylated by both
CC       receptor and non-receptor tyrosine kinases in vitro (By similarity).
CC       Tyrosine phosphorylation is required for AKT1-dependent phosphorylation
CC       of Ser-1417 (By similarity). Phosphorylation at Ser-1692 by PRKCQ
CC       disrupts interaction with GNAI3 and inhibits guanine nucleotide
CC       exchange factor activity (By similarity).
CC       {ECO:0000250|UniProtKB:Q3V6T2}.
CC   -!- DISRUPTION PHENOTYPE: CCDC88A knockout mice display mesial-temporal
CC       lobe epilepsy and early demise, and structural brain developmental
CC       defects affecting the corpus callosum and cerebrum.
CC       {ECO:0000269|PubMed:26917597}.
CC   -!- SIMILARITY: Belongs to the CCDC88 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH37020.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAI24877.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB087827; BAD98263.1; -; mRNA.
DR   EMBL; AL935054; CAI24877.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL935054; CAI24878.1; -; Genomic_DNA.
DR   EMBL; BX284634; CAI24878.1; JOINED; Genomic_DNA.
DR   EMBL; BX284634; CAI35999.1; -; Genomic_DNA.
DR   EMBL; BX284634; CAI36000.1; -; Genomic_DNA.
DR   EMBL; BX284634; CAI36001.1; -; Genomic_DNA.
DR   EMBL; AL935054; CAI36001.1; JOINED; Genomic_DNA.
DR   EMBL; BX284634; CAI36002.1; -; Genomic_DNA.
DR   EMBL; BC037020; AAH37020.1; ALT_INIT; mRNA.
DR   EMBL; AK082771; BAC38612.1; -; mRNA.
DR   CCDS; CCDS24494.1; -. [Q5SNZ0-2]
DR   RefSeq; NP_789811.2; NM_176841.4. [Q5SNZ0-2]
DR   RefSeq; XP_006514518.1; XM_006514455.3. [Q5SNZ0-1]
DR   AlphaFoldDB; Q5SNZ0; -.
DR   SMR; Q5SNZ0; -.
DR   BioGRID; 224370; 7.
DR   IntAct; Q5SNZ0; 3.
DR   STRING; 10090.ENSMUSP00000048978; -.
DR   iPTMnet; Q5SNZ0; -.
DR   PhosphoSitePlus; Q5SNZ0; -.
DR   EPD; Q5SNZ0; -.
DR   jPOST; Q5SNZ0; -.
DR   MaxQB; Q5SNZ0; -.
DR   PaxDb; Q5SNZ0; -.
DR   PeptideAtlas; Q5SNZ0; -.
DR   PRIDE; Q5SNZ0; -.
DR   ProteomicsDB; 271329; -. [Q5SNZ0-1]
DR   ProteomicsDB; 271330; -. [Q5SNZ0-2]
DR   ProteomicsDB; 271331; -. [Q5SNZ0-3]
DR   Antibodypedia; 47423; 255 antibodies from 33 providers.
DR   DNASU; 108686; -.
DR   Ensembl; ENSMUST00000040182; ENSMUSP00000048978; ENSMUSG00000032740. [Q5SNZ0-2]
DR   GeneID; 108686; -.
DR   KEGG; mmu:108686; -.
DR   UCSC; uc007igw.2; mouse. [Q5SNZ0-2]
DR   CTD; 55704; -.
DR   MGI; MGI:1925177; Ccdc88a.
DR   VEuPathDB; HostDB:ENSMUSG00000032740; -.
DR   eggNOG; KOG4643; Eukaryota.
DR   GeneTree; ENSGT00940000155559; -.
DR   HOGENOM; CLU_001421_1_0_1; -.
DR   InParanoid; Q5SNZ0; -.
DR   OMA; XEEKTEQ; -.
DR   OrthoDB; 59187at2759; -.
DR   PhylomeDB; Q5SNZ0; -.
DR   TreeFam; TF320231; -.
DR   Reactome; R-MMU-9696264; RND3 GTPase cycle.
DR   Reactome; R-MMU-9696273; RND1 GTPase cycle.
DR   BioGRID-ORCS; 108686; 3 hits in 73 CRISPR screens.
DR   ChiTaRS; Ccdc88a; mouse.
DR   PRO; PR:Q5SNZ0; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   RNAct; Q5SNZ0; protein.
DR   Bgee; ENSMUSG00000032740; Expressed in rostral migratory stream and 249 other tissues.
DR   ExpressionAtlas; Q5SNZ0; baseline and differential.
DR   Genevisible; Q5SNZ0; MM.
DR   GO; GO:0031252; C:cell leading edge; IDA:MGI.
DR   GO; GO:0005814; C:centriole; ISO:MGI.
DR   GO; GO:0005813; C:centrosome; IBA:GO_Central.
DR   GO; GO:0036064; C:ciliary basal body; ISO:MGI.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0003779; F:actin binding; ISS:UniProtKB.
DR   GO; GO:0051959; F:dynein light intermediate chain binding; IBA:GO_Central.
DR   GO; GO:0005154; F:epidermal growth factor receptor binding; ISS:UniProtKB.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; ISS:UniProtKB.
DR   GO; GO:0005092; F:GDP-dissociation inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; ISS:UniProtKB.
DR   GO; GO:0005158; F:insulin receptor binding; ISS:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0035091; F:phosphatidylinositol binding; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0043422; F:protein kinase B binding; IPI:UniProtKB.
DR   GO; GO:0005080; F:protein kinase C binding; ISS:UniProtKB.
DR   GO; GO:0042169; F:SH2 domain binding; ISS:UniProtKB.
DR   GO; GO:0043184; F:vascular endothelial growth factor receptor 2 binding; ISS:UniProtKB.
DR   GO; GO:0032147; P:activation of protein kinase activity; ISO:MGI.
DR   GO; GO:0032148; P:activation of protein kinase B activity; IDA:UniProtKB.
DR   GO; GO:0016477; P:cell migration; ISS:UniProtKB.
DR   GO; GO:0031122; P:cytoplasmic microtubule organization; IBA:GO_Central.
DR   GO; GO:0030705; P:cytoskeleton-dependent intracellular transport; IBA:GO_Central.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR   GO; GO:0030032; P:lamellipodium assembly; ISS:UniProtKB.
DR   GO; GO:0072660; P:maintenance of protein location in plasma membrane; ISS:UniProtKB.
DR   GO; GO:0061024; P:membrane organization; ISS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:0045724; P:positive regulation of cilium assembly; ISO:MGI.
DR   GO; GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:1903566; P:positive regulation of protein localization to cilium; ISO:MGI.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; ISO:MGI.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell population proliferation; IMP:UniProtKB.
DR   GO; GO:0006275; P:regulation of DNA replication; IMP:UniProtKB.
DR   GO; GO:0010975; P:regulation of neuron projection development; IDA:UniProtKB.
DR   GO; GO:0001932; P:regulation of protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; ISS:UniProtKB.
DR   GO; GO:0031929; P:TOR signaling; IDA:UniProtKB.
DR   Gene3D; 1.10.418.10; -; 1.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR027717; Girdin.
DR   InterPro; IPR043936; HOOK_N.
DR   PANTHER; PTHR18947:SF30; PTHR18947:SF30; 1.
DR   Pfam; PF19047; HOOK_N; 1.
DR   PROSITE; PS50021; CH; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cell projection;
KW   Cilium biogenesis/degradation; Coiled coil; Cytoplasm; Cytoplasmic vesicle;
KW   Cytoskeleton; DNA replication; Guanine-nucleotide releasing factor;
KW   Membrane; Neurogenesis; Phosphoprotein; Reference proteome.
FT   CHAIN           1..1873
FT                   /note="Girdin"
FT                   /id="PRO_0000287430"
FT   DOMAIN          12..132
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   REGION          816..841
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1013..1034
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1390..1408
FT                   /note="Phosphoinositide-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q3V6T2"
FT   REGION          1407..1459
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1560..1602
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1616..1643
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1715..1825
FT                   /note="SH2-like; required for interaction with growth
FT                   factor receptors"
FT                   /evidence="ECO:0000250|UniProtKB:Q3V6T2"
FT   REGION          1738..1873
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          196..425
FT                   /evidence="ECO:0000255"
FT   COILED          458..1232
FT                   /evidence="ECO:0000255"
FT   COILED          1268..1385
FT                   /evidence="ECO:0000255"
FT   MOTIF           1674..1704
FT                   /note="GBA"
FT                   /evidence="ECO:0000250|UniProtKB:Q3V6T2"
FT   COMPBIAS        1416..1459
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1745..1759
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1763..1821
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1833..1860
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         233
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         237
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         449
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3V6T2"
FT   MOD_RES         1020
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3V6T2"
FT   MOD_RES         1387
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3V6T2"
FT   MOD_RES         1417
FT                   /note="Phosphoserine; by PKB/AKT1"
FT                   /evidence="ECO:0000250|UniProtKB:Q3V6T2"
FT   MOD_RES         1421
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3V6T2"
FT   MOD_RES         1677
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:15345747,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         1692
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3V6T2"
FT   MOD_RES         1719
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3V6T2"
FT   MOD_RES         1767
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3V6T2"
FT   MOD_RES         1801
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3V6T2"
FT   MOD_RES         1822
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3V6T2"
FT   MOD_RES         1839
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3V6T2"
FT   VAR_SEQ         1000..1054
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_052410"
FT   VAR_SEQ         1463..1491
FT                   /note="MVALKRLPFLRNRPKDKDKMKACYRRSMS -> T (in isoform 2 and
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15753085"
FT                   /id="VSP_052411"
FT   CONFLICT        952
FT                   /note="Missing (in Ref. 2; CAI35999)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1086..1089
FT                   /note="LQRQ -> PRVR (in Ref. 3; AAH37020)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1873 AA;  215918 MW;  0E827E3D9336161F CRC64;
     MENEIFTPLL EQFMTSPLVT WVKTFGPLAA GNGTNLDEYV ALVDGVFLNQ VMLQINPKSE
     SQRVNKKVNN DASLRIHNLS ILVKQIKFYY QETLQQLIMM PLPDILIIGK NPFSEQGTEE
     VKKLLLLLLG CAVQCQKKEE FIEKIQGLDF DTKAAVAAHI QEVTHNQENV FDLQWMEVTD
     MSQEDIEPLL KNMVSHLRRL IDERDEHSET IVELSEERDG VHFLPHASSS AQSPCGSPGM
     KRTESRQHLS VELADAKAKI RRLRQELEEK TEQLLDCKQE LEQIEVELKR LQQENMNLLS
     DARSARMYRD ELDALREKAV RVDKLESELS RYKERLHDIE FYKARVEELK EDNQVLLETK
     TMLEDQLEGT RARSDKLHEL EKENLQLKAK LHDMEMERDM DRKKIEELME ENMTLEMAQK
     QSMDESLHLG WELEQISRTS ELAEAPQKSL GHEVNELTSS KLLKLEMENQ SLTKTVEELR
     STADSAAGST SKILKVEKEN QRLNKKVEIL ENEIIQEKQS LQNCQNLSKD LMKEKAQLEK
     TIETLRENSE RQIKILEQEN EHLNQTVSSL RQRSQISAEA RVKDIEKENK ILHESIKETC
     GKLSKIEFEK RQMKKELELY KEKGERAEEL ENELNHLGKE NELLQKKITN LKITCEKLET
     LEQENSELER ENRKFKKTLD SFKNLTFQLE SLEKENSQLD EENLELRRSV ESLKCASMRM
     AQLQLENKEL ESEKEQLRKG LELMRASFKK TERLEVSYQG LDTENQRLQK ALENSNKKIQ
     QLESELQDLE MENQTLQKSL EELKISSKRL EQLEKENKSL EQETSQLEKD KKQLEKENKR
     LRQQAEIKDT TLEENNVKIG NLEKENKTLF KEINVYKESC VRLKELEKEN KELVKRATID
     IKTLVTLRED LVSEKLKTQQ MNNDLEKLTH ELEKIGLNKE RLLHDEQSTD DSRYKLLESK
     LESTLKKSLE IKEEKIAALE ARLEESTNYN QQLRHELKTV KKNYEALKQR QDEERMVQSS
     IPVSGEDDKW GRESQEATRE LLKVKDRLIE VERNNATLQA EKQALKTQLK QLETQNNNLQ
     AQILALQRQT VSLQEQNTTL QTQNAKLQVE NSTLNSQSTS LMNQNAQLLI QQSSLENENE
     SIMKEREDLK SLYDALIKDH EKLELLHERQ ASEYESLISK HGTLKSAHKN LEVEHKDLED
     RYNQLLKQKG QLEDLEKMIK TEQEKMLLES KNHEVVASEY KKLCGENDRL NYTYSQLLKE
     TEILQMDHKN LKSVLNNSKL EQTRLEAEFS KLKEQYQQLD ITSTKLNNQC ELLSQLKGNL
     EEENRHLLDQ IQTLMLQNRT LLEQNMESKD LFHVEQRQYI DKLNELRRQK EKLEEKIMDQ
     YKFYDPSPPR RRGNWITLKM RKLIKSKKDI NRERQKSLTL TPTRSDSSEG FLQLPHQDSQ
     DSSSVGSNSL EDGQTLGTKK SSMVALKRLP FLRNRPKDKD KMKACYRRSM SMNDLVQSMV
     LAGGQWTGST ENLEVPDDIS TGKRRKELGA MAFSTTAINF STVNSSAAFR SKQLVNNKDT
     TSFEDISPQG ISDDSSTGSR VHASRPASLD SGRTSTSNSN NNASLHEVKA GAVNIQSRPQ
     SHSSGDFSLL HDHETWSSSG SSPIQYLKRQ TRSSPMLQHK ISETIESRAH HKMKAGSPGS
     EVVTLQQFLE ESNKLTSIQL KSSSQENLLD EVMKSLSVSS DFLGKDKPVS CTLARSVSGK
     TPGDFYDRRT TKPEFLRTGP QKTEDAYTIS SAGKPTPSTQ GKIKLVKETS VSRQSKDSNP
     YATLPRASSV ISTAEGTTRR TSIHDFLSKD SRLPVSVDSS PPTAGSSSTT ASNVNKVQES
     RNSKSRSREQ QSS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024